- Home
- APVO vs CTRM Comparison
APVO vs CTRM Comparison
Compare APVO & CTRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APVO
- CTRM
- Stock Information
- Founded
- APVO 2016
- CTRM 2016
- Country
- APVO United States
- CTRM Cyprus
- Employees
- APVO N/A
- CTRM N/A
- Industry
- APVO Biotechnology: Pharmaceutical Preparations
- CTRM Marine Transportation
- Sector
- APVO Health Care
- CTRM Consumer Discretionary
- Exchange
- APVO Nasdaq
- CTRM Nasdaq
- Market Cap
- APVO 21.7M
- CTRM 21.2M
- IPO Year
- APVO N/A
- CTRM N/A
- Fundamental
- Price
- APVO $1.09
- CTRM $1.88
- Analyst Decision
- APVO
- CTRM
- Analyst Count
- APVO 0
- CTRM 0
- Target Price
- APVO N/A
- CTRM N/A
- AVG Volume (30 Days)
- APVO 757.7K
- CTRM 38.7K
- Earning Date
- APVO 11-06-2025
- CTRM 11-07-2025
- Dividend Yield
- APVO N/A
- CTRM N/A
- EPS Growth
- APVO N/A
- CTRM N/A
- EPS
- APVO N/A
- CTRM N/A
- Revenue
- APVO N/A
- CTRM $67,859,415.00
- Revenue This Year
- APVO N/A
- CTRM N/A
- Revenue Next Year
- APVO N/A
- CTRM N/A
- P/E Ratio
- APVO N/A
- CTRM N/A
- Revenue Growth
- APVO N/A
- CTRM N/A
- 52 Week Low
- APVO $1.07
- CTRM $1.84
- 52 Week High
- APVO $298.00
- CTRM $3.64
- Technical
- Relative Strength Index (RSI)
- APVO 27.92
- CTRM 38.93
- Support Level
- APVO $1.39
- CTRM $1.85
- Resistance Level
- APVO $1.54
- CTRM $2.09
- Average True Range (ATR)
- APVO 0.09
- CTRM 0.08
- MACD
- APVO -0.03
- CTRM -0.01
- Stochastic Oscillator
- APVO 3.06
- CTRM 20.00
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.
About CTRM Castor Maritime Inc.
Castor Maritime Inc is a provider of seaborne transportation services for dry bulk cargo, including iron ore, coal, grain, steel products, fertilizers, cement, bauxite, sugar, and scrap metal, among others. The firm operates under three reportable segments namely (i) the dry bulk segment (ii) the containership segment and (iii) the asset management segment. It generates maximum revenue from the Dry bulk segment.